The Cost-effectiveness Analysis of Chuanhuning and Ribavirin in Treatment of Viral Pneumonia / 中国药房

OBJECTIVE:To compare the therapeutic effect and cost-effectiveness ratio between chuanhuning and rib?avirin in treatment of viral pneumonia.METHODS:63patients with viral pneumonia were divided into chuanhuning and rib?avirin groups and pharmacoeconomic cost-effectiveness analysis was carried out.RESULTS&CONCLUSION:In treating viral pneumonia,there is a great disparity in price between chuanhuning and ribavirin,however,the costs of two groups were very close,and so were the cost-effectiveness ratios.Chuanhuning is better than ribavirin in paying.